|Application:||Gene expression microarray analysis|
|Number of samples:||8|
|Release date:||Oct 9 2016|
|Last update date:||Aug 13 2018|
|Dataset link||Secondary proteasome inhibitor carfilzomib resistant myeloma cell lines|
We generated carfilzomib-resistant (CR) myeloma cell lines by exposing drug-naive ANBL-6, KAS-6/1, U266, and OPM-2 cells to increasing concentrations of carfilzomib. These were then subjected to gene expression profiling (GEP) to identify prominent changes compared to their vehicle-treated counterparts.